Representation in Clinical Trials

Research institutions have long struggled with accurate population representation in clinical trials. The growing proliferation of digital in healthcare ecosystems makes this more likely, but it is not perfect. UCLA Health’s Dr. Arash Naeim and Dr. Medell Briggs-Malonson share their efforts to progress the intersectionality of health technology and health audience in clinical trials and beyond. Verizon’s Robin Goldsmith and Ned Chini round out this conversation with the role devices and connectivity play in achieving representation.

Recent Episodes

In a groundbreaking move, CGFNS International has launched the first-ever global specialty credential for rehabilitation nurses, the Certified Global Nurse Rehabilitation (CGNR) exam. This credential marks a pivotal step toward addressing the critical need for globally standardized competencies in rehabilitation care. The development of this certification was a multi-year effort, uniting rehabilitation specialists from diverse…

Healthcare facilities face significant challenges in procuring and managing medical imaging equipment. These high-cost, high-stakes purchases, such as MRI and CT scanners, can directly impact patient care and financial sustainability. With declining reimbursements and increasingly complex technologies, the importance of expert guidance in making these decisions has never been greater. In fact, in 2022,…

Erin Osbourn, CIO at the Child Mind Institute, shares her experiences at the Chime Fall Forum and highlights the importance of building a culture of inclusion, belonging, and work-life harmony within her team. She discusses her leadership approach of fostering vulnerability, empathy, and balance, while emphasizing the critical need to destigmatize mental health, especially in…